Search by Drug Name or NDC

NDC 47335-0177-01 ILUMYA 100 mg/mL Details

ILUMYA 100 mg/mL

ILUMYA is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is TILDRAKIZUMAB.

MedlinePlus Drug Summary

Tildrakizumab-asmn injection is used to treat moderate to severe plaque psoriasis (a skin disease in which red, scaly patches form on some areas of the body) in people whose psoriasis is too severe to be treated by topical medications alone. Tildrakizumab-asmn injection is in a class of medications called monoclonal antibodies. It works by stopping the action of certain natural substances in the body that cause the symptoms of psoriasis.

Related Packages: 47335-0177-01
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Tildrakizumab-asmn injection

Product Information

NDC	47335-0177
Product ID	47335-177_e811aee5-936e-46a9-bb7d-9a387bdb505f
Associated GPIs	9025058010E520
GCN Sequence Number	078258
GCN Sequence Number Description	tildrakizumab-asmn SYRINGE 100 MG/ML SUBCUT
HIC3	L1A
HIC3 Description	ANTIPSORIATIC AGENTS,SYSTEMIC
GCN	44553
HICL Sequence Number	044823
HICL Sequence Number Description	TILDRAKIZUMAB-ASMN
Brand/Generic	Brand
Proprietary Name	ILUMYA
Proprietary Name Suffix	n/a
Non-Proprietary Name	tildrakizumab-asmn
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	INJECTION, SOLUTION
Route	SUBCUTANEOUS
Active Ingredient Strength	100
Active Ingredient Units	mg/mL
Substance Name	TILDRAKIZUMAB
Labeler Name	Sun Pharmaceutical Industries, Inc.
Pharmaceutical Class	Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]
DEA Schedule	n/a
Marketing Category	BLA
Application Number	BLA761067
Listing Certified Through	2024-12-31

Package

NDC 47335-0177-01 (47335017701)

Pricing Information	N/A
NDC Package Code	47335-177-01
Billing NDC	47335017701
Package	1 mL in 1 SYRINGE, GLASS (47335-177-01)
Marketing Start Date	2018-08-06
NDC Exclude Flag	N